NanoSessions: Disruptive Technology is Being Used to Reduce Interruptions

 

A common refrain heard in the Pro AV space is the admiration for all of the newest technological advances. On this episode of NanoLumens’ NanoSessions, Joel Krieger, Chief Creative Officer for Second Story, sat down with host Sean Heath and they discussed how the newest disruptive technologies are being used in more subtle ways.

Generally speaking, digital displays have followed a path similar to that of the internet, according to Krieger.

“In the beginning, the internet was pretty interesting and it was like the Wild West. Eventually, it got commercialized and advertising began to really take over,” he said.

The digital display industry initially fell into the same pattern of prioritizing the advertising disruption, however, Krieger feels that is changing rapidly.

“We once again have a moment to kind of think about how we treat the ‘built environment’ and how we activate these canvases in a way that’s in service of the people and the business,” he explained.

The recent unveiling of a massive lobby installation, titled “Unify”, reinforces Krieger’s feeling that the next evolution of display technology application will be markedly different that the current digital modality.

“With Unify, we’re not trying to communicate a message; we’re trying to create a feeling for a space,” said Krieger. “There are other ways to calculate value or return on investment from a media piece and it’s not always ‘how many impressions of your advertising message can you get across?’.”

Redefining the purpose of the display is a way of acknowledging the impact of the message displayed on it, as well, according to Krieger.

“What’s the value of how your employees feel in your building? How do you put a value on that,” he asked.

For the latest news, videos, and podcasts in the Pro AV Industry, be sure to subscribe to our industry publication. A new episode of the Pro AV Show drops every Thursday.

Follow us on social media for the latest updates in B2B!

Twitter – @ProAVMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Agentic AI
Agentic AI: IBM is Powering the Next Wave of Autonomous, Intelligent Decision-Making
March 14, 2025

Retail has long embraced automation, but now it’s taking a leap into a new frontier—autonomous decision-making. Enter agentic AI, a technology that doesn’t just automate tasks but makes real-time, intelligent decisions. With major retailers like Walmart integrating AI-driven fulfillment robots and brands such as Bath & Body Works rolling out personalized AI-powered shopping assistants,…

Read More
QSR connectivity
How IBM and Hughes Are Powering the Future of QSR Connectivity & Fast Food Tech
March 14, 2025

Quick service restaurants (QSRs) are under increasing pressure to enhance speed, efficiency, and customer experience—all while managing a growing network of digital systems. From AI-powered ordering kiosks to real-time kitchen automation, modern QSRs are more connected than ever. The restaurant AI market was valued at $9.68 billion in 2024, and expected to reach $49 billion…

Read More
Trade tariffs
From Asia to the World: How Dimerco is Helping Businesses Navigate New Trade Tariffs and Supply Chain Shifts
March 13, 2025

The global supply chain is once again at a crossroads, with shifting trade policies, geopolitical tensions, and economic fluctuations shaping the way goods move across the world. The looming threat of new trade tariffs on imports from Asia, combined with fluctuating shipping rates, is creating a challenging landscape for logistics professionals. With businesses re-evaluating…

Read More
sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More